Previous 10 | Next 10 |
Application based on results from the TROPION-Lung01 phase 3 trial If approved, Daiichi Sankyo and AstraZeneca’s datopotamab deruxtecan may be the first TROP2 directed antibody drug conjugate for patients with lung cancer Daiichi Sankyo (TSE: 4568) and AstraZeneca’s (L...
2024-02-18 02:05:00 ET Summary LianBio plans to stop all its operations by the end of 2024 and will distribute a $4.80 dividend/share ($528M) to its shareholders. Yiviva signed a memorandum of understanding with AstraZeneca China for an R&D collaboration at AstraZeneca’...
Approval based on FLAURA2 results which showed TAGRISSO plus chemotherapy extended median progression-free survival by nearly 9 months vs. standard of care AstraZeneca’s TAGRISSO ® (osimertinib) with the addition of chemotherapy has been approved in the US for the trea...
2024-02-15 15:00:53 ET Summary Aurinia Pharmaceuticals Inc. stock price dropped 25% after underwhelming Q4 and full-year 2023 results. Sales of Lupkynis, indicated for lupus nephritis and the company's only commercial product, have failed to meet expectations. Aurinia has init...
2024-02-13 12:00:57 ET Summary Despite higher-than-expected inflation, stock markets remained largely unaffected, with the Dow Jones, Nasdaq, and S&P 500 Indices ignoring the news. Inflation for all items increased by 3.4%, with the shelter index accounting for two-thirds of t...
2024-02-13 09:47:09 ET Citigroup Inc (C) C is trading DOWN for the last 4 days, and it at trading at $52.62 with volume of 4,254,783 and a one day change of $-1.30 (-2.41%). Citigroup Inc has a 52-week low of 38.17 and a 52-week high of $57.95. The business's 50-day moving average p...
A look at the top 10 most actives in the United States Beamr Imaging Ltd. (BMR) rose 371.6% to $9.95 on volume of 154,937,988 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 0.7% to $4.34 on volume of 137,498,905 shares Arm Holdings plc (ARM) rose 29.3% to $148.97 on volume...
2024-02-13 05:50:00 ET Weight-loss drugs are hot. Just look at the recent performances of Eli Lilly (NYSE: LLY) , which won U.S. approval in November for Zepbound, and Novo Nordisk (NYSE: NVO) , which markets Ozempic and Wegovy. Lilly's share price has soared more than 115% ...
2024-02-13 00:50:00 ET Summary Let's take a look at the landscape for GLP-1 drug development (including the drugs that target associated hormones). Novo Nordisk has had a spectacular success with semaglutide (Ozempic/Wegovy), and its effects on weight loss have been established to...
2024-02-12 21:01:27 ET More on Bristol-Myers Squibb Company , Eli Lilly, etc. Pfizer Stock: It's Time To Buy The Dip Pfizer Is A Great Investment Over The Next Decade; Buy Will Eli Lilly and Company Become A Trillion-Dollar Baby? RayzeBio ticks higher af...
News, Short Squeeze, Breakout and More Instantly...
2024-07-20 00:14:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-02 08:30:07 ET Jefferies analyst issues HOLD recommendation for AZN on July 2, 2024 06:20AM ET. The previous analyst recommendation was Hold. AZN was trading at $77.94 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analys...